Lewy
Body
Dementia
2026 Program

The Lewy Body Dementia 2026 Program provides catalyst funding for high-risk, high-reward translational research focused on biomarkers and symptom-focused treatments for Dementia with Lewy Bodies (DLB) and Parkinson’s Disease Dementia (PDD).
LETTER OF INTENT DEADLINENovember 17, 2026